© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
June 09, 2021
The COVID-19 pandemic had forced vitiligo patients to delay treatments; however, not much is known about the effects of delaying on disease course.
June 07, 2021
Misha Rosenbach, MD, gives an overview of climate change and its relevance to dermatology.
June 04, 2021
Meaningful change thresholds in POEM and DLQI scores have been established for adolescents and adults.
June 02, 2021
There may be an association between atopic dermatitis severity and diagnosis of ocular disease, such as conjunctivitis.
June 01, 2021
Secukinumab is the only fully human biologic that directly inhibits IL-17A.
May 30, 2021
Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of dermatology.
May 21, 2021
In both studies, a higher proportion of patients on upadacitinib 15 mg and 30 mg achieved EASI-75, EASI-90, and EASI-100 compared with the placebo groups.
May 20, 2021
Internet-delivered CBT may be an efficient and convenient means for addressing behaviors that exacerbate atopic dermatitis-related symptoms.
May 19, 2021
Patients treated with ruxolitnib cream show ≥75% improvement in facial vitiligo scoring index.
May 13, 2021
Patients who received 2 mg or 4 mg of baricitinib maintained vIGA-AD scores through 68 weeks of treatment.